HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assays], Molecular Assays [PCR Based Molecular Assays, Sequencing Based Molecular Assays {Sanger Sequencing, Next Generation Sequencing}]), By Product and Services (Instruments, Reagents & Consumables, Software, Services), By Application (Diagnostics, Research), By End-use (Hospitals, Academic & Research Institutes), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

Industry Trends

HLA Typing for Transplant Market size valued at over USD 667.8 million in 2021 and is expected to witness more than 7.8% CAGR between 2022 and 2028. Rising geriatric population will act as high impact rendering factor for the market growth. This is attributed to growing number of chronic disorders among geriatric population which is leading to permanent organ damage.
 

Get more details on this report - Request Free Sample PDF
 

The spread of COVID-19 pandemic across the globe had a minimal impact on market in 2020. Various companies registered a slowdown in testing service volumes in the final weeks of March and during April 2020 as well as faced significant challenges in exporting the products. This can be credited to increasing number of COVID-19 infections along with restrictions, delaying or postponing of the non-essential surgical including organ transplant and non-invasive procedures. These procedures are not considered as critical or life-saving procedure and hence, come under elective surgical procedures.
 

Healthcare organizations were performing more out-patient elective surgical procedures, as countries and states begin to ease few COVID-19 restrictions. However, securing slots for bone marrow harvest makes extremely difficult for lab technicians and hospitals, as health care organizations have a backlog of surgeries. This provision of suboptimal supervision may hinder HLA typing for transplant to some extent during the forecast timeframe.
 

Technological advancements in HLA typing will spur the market expansion

Technological advancements in molecular assays segment are driving the global HLA Typing for transplant market progression. Presently, target specific PCR method is used to screen disease causative pathogen. Also, companies are focusing on development of novel platforms for HLA typing.
 

High cost associated with molecular test in HLA typing is hampering the market value

Increasing utilization of molecular diagnostics in HLA typing has led to upsurge in its costs. Rising demand for molecular diagnostics due to its ability to deliver accurate results in less time has created pressure on industry players to develop new products and to satisfy growing consumer demands. Majority of laboratories perform several molecular tests using hematology and chemistry analyzers. Additionally, as per the National Human Genome Research Institute, gene sequencing test cost around USD 5,000 to USD 10,000 per test which is not affordable to majority of population.
 

Molecular assays segment will dominate the industry growth

The molecular assays segment dominated more than 83.5% of the market share in 2021. Growing demand for molecular assays and increasing adoption rate along with advanced technologies that encourage customer buying behaviour are the major factors driving the industry expansion during the forecast timeframe. Also, associated advantages provided by molecular techniques are effective as compared to non-molecular assays that boost the demand for molecular assays segment growth.
 

The molecular assays are sub-classified into PCR based and sequencing based molecular assays. PCR technique is used for fast recognition of pathogens thus, became popular among the healthcare professionals and patients, thereby supplementing the industry revenue. Moreover, together with conventional PCR methods, the real-time PCR (RT-PCR) has developed as innovative technology and is increasingly being used in research laboratories and clinical diagnostics.
 

Availability of diverse types of kits in the market to serve as growth opportunity

Get more details on this report - Request Free Sample PDF
 

The reagents and consumables segment in the HLA typing for transplant market exceeded USD 341.5 million in 2021. Reagents and consumables are used in large quantity and are frequently required for performing HLA typing. Thus, rising acceptance of reagents and consumables in transplant diagnostic technique is poised to impel the industry progression. Also, introduction of recent technologies causing development as well as enhancement of instruments stimulates the segment expansion in coming years. In addition, availability of diverse types of kits such as SBT kits (sequencing-based typing), SSO kits (sequence-specific oligonucleotides), SSP kits (sequence-specific primers) will stimulate the segment value.
 

Increasing application in diagnosis and availability of advanced & more specific gene testing techniques will foster the segment progression

The diagnostics segment is predicted to reach USD 881.2 million by 2028 led by the wide-ranging application in disease diagnosis coupled with availability of advanced and more specific gene testing techniques. Additionally, increasing implementation of HLA typing with PCR and other sequencing devices in healthcare administrations including diagnostics and advancements in research & development activities will accelerate the industry value. Moreover, the need for HLA matched bone marrow transplantation treatment for couples at risk with thalassaemic children is further slated to propel the industry size.
 

Growing number of HLA testing due to high demand for transplant procedures to augment the segment demand

The diagnostic lab is anticipated to showcase 8.1% growth rate through 2028 impelled by the increasing number of HLA testing due to high demand for transplant procedures. For instance, according to the Global Observatory on Donation & Transplantation, nearly 157,301.0 organ transplantation were performed in 2019. The report also stated that, around 150,407.0 organ transplantation were performed in 2018.
 

Presence of majority of companies will influence the North America market revenue

Get more details on this report - Request Free Sample PDF
 

North America HLA typing for transplant market held 35.6% of revenue share in 2021 on account of the increased demand for organ transplant coupled with rising governments initiatives to support ethical progress of organ donation and transplantation programs. Moreover, presence of prominent players that offer advanced technologies will fuel the business growth. Factors such as large number and sizes of laboratories and availability of highly skilled professionals in the region is set to propel the regional growth. Furthermore, Availability of large number of laboratories and highly skilled professionals in the region will further boost the regional expansion.
 

Adoption of business strategies will pave growth opportunities for companies operating in the market

Prominent players operating in the market include Abbott, Bio-Rad Laboratories, CareDx, Qiagen N.V., Thermo Fischer Scientific, F. Hoffmann-La Roche Ltd, Illumina Inc, Luminex Corporation and Immucor, Inc. Partnerships & collaborations, geographical expansion, product approval & launch are the most commonly adopted business strategies to sustain market competition.
 

The HLA typing for transplant market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

Market, By Technology

• Non-molecular assays
  • Serological assays
  • Mixed lymphocyte culture assays
• Molecular assays
  • PCR based molecular assays
  • Sequencing based molecular assays
    • Sanger sequencing
    • Next generation sequencing

Market, By Product and Services

• Instruments
• Reagents and consumables
• Software
• Services

Market, By Application

• Diagnostics
• Research

Market, By End-use

• Hospitals
• Diagnostic labs
• Academic and research institutes

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia